Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

TECFIDERA prescribing information
Nancy Davis Foundation Annual MS Expo and Health Forum
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Episode 4 with Dr. Michael Racke on the Kir4.1 potassium channel
Demyelination of the hippocampus is prominent in the cuprizone model.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress
Experimental models of spontaneous autoimmune disease in the central nervous system.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
ACRM I American Congress of Rehabilitation

Pages